Hib (Haemophilus Influenzae Type B) Vaccine Suppliers & Bulk Manufacturers
Available Forms: Injectable suspension (IM injection)
Available Strengths: 0.5 mL
Reference Brands: PedvaxHIB,ActHIB(US)
Category:
Vaccines
Hib vaccine stimulates the immune system to produce antibodies against Haemophilus influenzae type b bacteria. It prevents invasive diseases like meningitis, pneumonia, and sepsis, reducing morbidity and mortality. Benefits include long-lasting immunity, disease reduction, and protection of vulnerable infants and children from serious bacterial infections.
Hib (Haemophilus influenzae type b) Vaccine is available in Injectable suspension (IM injection)
and strengths such as 0.5 mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Hib (Haemophilus influenzae type b) Vaccine is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Hib (Haemophilus influenzae type b) Vaccine can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Hib (Haemophilus influenzae type b) vaccines are approved in both the US and EU, supported by dossiers demonstrating safety, efficacy, and high manufacturing standards aligned with GMP standards. In the US, FDA oversight requires clinical evaluation and safety profiles, while in the EU, CE marking certifies conformity with in vitro diagnostic regulations. These vaccines undergo validation, stability testing, and comprehensive audits, with detailed documentation including safety data, clinical trial results, and manufacturing practices. For licensing procedures, approved dossiers, and latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to safe and effective Hib vaccines, critical for preventing invasive bacterial diseases worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing